Benefits of using CGM vs BGM

Reduces HbA1c with reductions in hypoglycemia events, increased time within target glucose range (TIR), and reductions in time below range

Significantly reduces glycemic variability and the time spent in hypoglycemia among T2D adults treated with intensive insulin therapy

A strong link between CGM use and reductions in hospitalizations for DKA and severe hypoglycemia has also been reported

Also, use of CGM has potential benefits in managing cardiovascular disease and patients with ESRD

The Ambulatory Glucose Profile (AGP) report allow a consistent visualization format (numerical and graphs) for rapid identification of most significant glucose patterns to guide therapy decisions and enhance patient-clinician collaboration

Virtual telehealth visits combined with remotely monitoring CGM improves glycemic control, reduces diabetes-distress, and enhances patients’ adherence to prescribed therapy, with increased time and cost-efficiency vs in-clinic diabetes care